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Summary 
We have constructed a “minilocus” that contains the 5’ 
and 3’ flanking regions of the human P-globin locus 
and the B-globin gene. These regions are character- 
ized by erythroid-specific DNAase I-superhypersensi- 
tive sites and are normally located approximately 50 
kb 5’ and 20 kb 3’ of the P-globin gene. This minilocus 
is expressed tissue-specifically in transgenic mice at 
a level directly related to its copy number yet indepen- 
dent of its position of integration in the genome. 
Moreover, the expression per gene copy is the same 
in each mouse and as high as that of the endogenous 
mouse P-globin gene. These results indicate that the 
DNA regions flanking the human P-globin locus con- 
tain dominant regulatory sequences that specify posi- 
t ion-independent expression and normally activate 
the complete human multigene P-globin locus. 
Introduction 
The human p-like globin genes are a cluster of five active 
genes, in the order 5’-~-~y+6+3’, comprising approxi- 
mately 60 kb of DNA on the short arm of chromosome 11. 
The different genes are expressed in a developmental- 
stage- and tissue-specific manner, i.e., the embryonic E 
gene is expressed in the yolk sac, the fetal Gy  and 9 
genes are expressed primarily in the fetal liver, and the 
adult 6 and p genes are expressed primarily in bone mar- 
row (for review, see Maniatis et al., 1961). Mutations in this 
gene family lead to a broad spectrum of genetic diseases; 
a large number of these mutations have been character- 
ized, ranging from simple amino acid changes by point 
mutations to complete deletions of the locus (for review, 
see Collins and Weissman, 1964). These often lead to se- 
vere clinical problems and early death. Conventional 
treatment of these diseases (by transfusion) is costly, 
risky, and in many cases inadequate. Since bone marrow 
is accessible, this type of disease is a prime candidate for 
“gene therapy” (Hock and Miller, 1986). A number of 
laboratories, including our own, have made progress in 
delineating the cis-acting DNA sequences necessary for 
the transcription of the P-globin gene, using DNA-medi- 
ated gene transfer both in tissue culture cells-in particu- 
lar, murine erythroleukaemia (MEL) cells-and in trans- 
genie mice. 
It is clear that the DNA sequences regulating the human 
@globin gene are located both 5’ and 3’ to the translation 
initiation site (Wright et al., 1984; Charnay et al., 1984). 
Using MEL and K562 cells we have now identified at least 
four separate regulatory elements required for the appro- 
priate expression of the human S-globin gene: a positively 
acting globin-specific promoter element, a putatively 
negative regulatory promoter element, and two down- 
stream regulatory sequences (enhancers),  one located in 
the gene and one approximately 800 bp downstream of 
the gene (Antoniou and Grosveld, submitted). A similar 
enhancer has also been identified downstream of the 
chicken P-globin gene in cultured chicken erythroid cells 
(Hesse et al., 1986; Choi and Engel, 1986). The down- 
stream enhancer has been shown to be a developmental- 
stage-specific enhancer by using transgenic mice (Kollias 
et al., 1986, 1987; Behringer et al., 1987). All of these 
results therefore indicate that multiple developmental- 
stage-specific control regions of the P-globin gene are lo- 
cated immediately 5: inside, and 3’ of the B-globin gene. 
However,  when a P-globin gene containing all of these 
control regions is introduced into transgenic mice, the 
gene is never expressed at the same level as the mouse 
S-globin gene, and exhibits position effects. This is 
characterized by a highly variable expression of the trans- 
gene that is not correlated with the copy number of the in- 
jected gene in the mouse genome. The same phenome- 
non has been observed with almost all the genes that 
have been studied in transgenic mice (Palmiter and Brin- 
ster, 1986). Moreover, in the case of S-globin the level of 
expression of each injected gene is at best an order of 
magnitude below that of the endogenous mouse gene 
(Magram et al., 1985; Townes et al., 1985; Kollias et al., 
1986). A similar problem is observed when the P-globin or 
other genes are introduced into cultured cells by transfec- 
tion or retroviral infection. This poses a big problem in the 
context of gene therapy by gene addition in stem cells. 
Our  tentative interpretation of this position effect is that the 
injected DNA does not have sufficient sequence informa- 
tion to be independent of the effect of the integration 
locus. 
The strongest evidence for the existence of such control 
sequences has come from the analysis of human rP- 
thalassemias (Van der Ploeg et al., 1980; Curtin and Kan, 
1987). Patients with Dutch thalassemia are heterozygous 
for a large deletion that removes 100 kb upstream of the 
/3-globin gene but leaves the P-globin gene, including all 
of the control regions described above, intact (Kioussis et 
al., 1983; Wright et al., 1984; Taramelli et al., 1986). Since 
the patient is heterozygous and transcribes the normal lo- 
cus in the same nucleus, some control mechanism must 
override the functioning of the control sequences immedi- 
ately surrounding the genes in the mutant locus. In the 
case of the Dutch y&thalassemia, it could indeed be 
shown that the mutant locus is in an inactive chromatin 
configuration and has a classical position effect (Kioussis 
et al., 1983). Possible candidate sequences for activation 
control are the regions upstream of the s-globin gene and 
downstream of the B-globin gene, which contain a number 
of “superhypersensit ive” sites. These sites are more sensi- 
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Figure 1. Mapping DNAse l-Hypersensitive Sites 5’ of the s-Globin Gene 
(A) Nuclei of HEL cells were incubated with DNAase I (60 pglml) at 3PC, and aliquots were removed from the reaction at the times indicated (in 
min) above the lanes. Control aliquots of approximately lo7 HEL nuclei were incubated in the absence of DNAase I (0 en,?.) or in the presence of 
30 units of Alul (A) or 60 units of Hinfl (Hf) for 15 min at WC. DNA was purified after proteinase K digestion, recut with AspiTE, fractionated on 
a 0.8% agarose gel, transferred to nitrocellulose, and probed with an s-globin gene probe (BamHI-EcoRI 1.4 kb). Hypersensitive sites (HSSs) are 
indicated at left; see (E). 
(B) The DNAase l-digested samples of (A) were recut with Bglll and probed with a 3.3 kb EcoRl fragment that detects, in addition to 12.0 and 5.8 
kb bands, a cross-hybridizing band of 6.8 kb after filters are washed at a stringency of 0.3x SSC at 65°C. This fragment is not observed after washing 
in 0.1 x SSC at 65’C (not shown). 
(C) Nuclei of PUTKO cells were digested with DNAase I (20 pglml) at 3pC, and samples were removed from the reaction after 1, 2, 4, and 8 min, 
as indicated. A control aliquot of approximately IO7 nuclei was incubated for 8 min at 37% in the absence of DNAase I(0 enz.). After recutting of 
the DNA with BamHI. gel electrophoresis, and transfer to nitrocellulose, the filter was hybridized with a 0.46 kb EcoRI-Bglll probe and washed at 
a final stringency of 0.3x SSC at 65%. 
(D) Nuclei of human T cell line J6 were digested with DNAase I(20 uglml) at 37°C for the times indicated (in min). After recutting of the DNA with 
AspTIE, gel electrophoresis, and transfer to nitrocellulose, the filter was hybridized with the 0.46 kb EcoRI-Bglll probe and washed in 0.3x SSC 
at 85%. That DNAase I digestion had occurred was shown by reduction of the size average of bulk DNA and the appearance of DNAase I-hypersensi- 
tive sites around T-cell-specific genes (not shown). 
(E) Shows a restriction map of the 8globin locus upstream of the s-globin gene for the three restriction enzymes used in these experiments. Locations 
of probes and deduced positions of DNAase l-hypersensitive sites (numbered) in HEL and PUTKO cell chromatin are marked. 
tive to DNAase I digestion than the hypersensit ive sites 
found in and around the individual genes during gene ex- 
pression (Tuan et al., 1985; Forrester et al., 1986; Grou- 
dine et al., 1983). In addition, they are erythroid-cell- 
specific and are present when any one of the globin genes 
is expressed. We have tested the possible role of these se- 
quences by using transgenic mice, and we show that 
these sequences can be used to obtain completely regu- 
lated, high-level f3-globin gene expression independent of 
the position of the transgene. We discuss the role of these 
sequences and propose a model for the mechanism of 
globin switching during development. 
Results 
et al., 1985; Kollias et al., 1986). The aim therefore was to 
establish whether dominant control regions are present in 
the flanking regions, by including such regions on a p-glo- 
bin construct. If such sequences are insensitive to posi- 
tion effects, we would expect, first, that the level of expres- 
sion of the construct is directly related to its copy number 
in the transgenic mice; second, that the level of expres- 
sion per gene copy is the same in each mouse; and third, 
that the introduced gene may be expressed at a level com- 
parable to that of the mouse genes. Prior to testing the 5’ 
and 3’ sequences, we wanted to map the positions of the 
hypersensit ive sites carefully since their exact positions, 
especially at the 3’ side, have not been published in detail 
(Tuan et al., 1985). 
The rationale behind the experiments was provided by the Mapping DNAase l-Hypersensitive Sites 
position effects observed in certain thalassemias (Kious- Flanking the S-Globin Locus 
sis et al., 1983) and after injection of small 6-globin con- Very limited DNAase I digestion of nuclei of erythroid cells 
structs in transgenic mice (Magram et al., 1985; Townes reveals extremely sensitive sites upstream of the c-globin 
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Figure 2. Mapping the DNAase I-Hypersensitive Site 3’ of the Human !3-Globin Gene 
(A-D) show DNA from DNAase I-digested nuclei of HEL cells recut with the indicated restriction enzymes and probed with either a 1.15 kb EcoRl 
fragment or a 1.1 kb Hindlll-BamHI fragment; abbreviations are as in Figure 1. Both DNA probes contain some human repetitive DNA, which necessi- 
tated the use of IO pg sheared human DNA per ml in prehybridization and hybridization buffers. Filters were washed at a final stringency of 0.3x 
SSC at 65%. (E) shows a restriction map of the P-globin locus 3’of the b-globin gene; the positions of the two probes used and the 3’hypersensitive 
site are marked. The position of hypersensitive site 5 was confirmed by probing Hindlll- and Bglll-recut DNA samples with the 1.15 kb EcoRl probe 
(not shown). 
gene and downstream of the /3-globin gene (Tuan et al., 
1985). We fine-mapped the DNAase l-hypersensitive 
sites relative to restriction sites mapped in our cosmids 
(Taramelli et al., 1986). Figures lA-1C show time courses 
of DNAase I digestion on nuclei of HEL (Martin and 
Papayannopoulou, 1982) and PUTKO (Klein et al., 1980) 
cells recut with various restriction enzymes, Southern 
blotted, and hybridized with a number of probes upstream 
of the &-globin gene (see Figure 1E). Four hypersensit ive 
sites are present, at 18 kb (site l), 15 kb (site 2), 12.0 and 
11.5 kb (sites 3a and 36), and 5.4 kb (site 4) upstream of 
the &-globin gene. Sites 1,3a, and 4 are strongly hypersen- 
sitive, as judged by their early appearance during the time 
course of digestion. Sites 2 and 3b are weaker and appear 
later during digestion. Figure 1D shows DNAase I diges- 
tion of nuclei of human T cell line J6 (Gillis and Watson, 
1981). DNAase l-hypersensitive sites 5’of E are not seen. 
Similar results were obtained with HeLa cell nuclei, show- 
ing the erythroid-specific nature of these hypersensit ive 
sites. 
The exact location of the DNAase l-hypersensitive site 
3’ of the adult D-globin gene was determined using two 
single-copy DNA probes and several restriction enzyme 
digests of DNAase l-digested HEL cell nuclei. The data 
summarized in Figures 2A-2D show that there is a single 
DNAase l-hypersensitive site between the 2.3 kb Bglll 
fragment and the 2.4 kb Hindlll fragment approximately 
20 kb 3’ of the adult p-globin gene (Figure 2E). Similar 
results were obtained with DNAase l-digested PUTKO 
cell nuclei (data not shown). 
Construction of the [3-Globin “Minilocus” 
The globin “minilocus” (Figure 3) was constructed from 
three regions (see Experimental Procedures for the pre- 
cise description): a 21 kb region immediately upstream of 
the &-globin gene (-1 kb Clal to -22 kb Bglll) containing 
all four hypersensit ive sites (Figure l), a 4.7 kb Bglll frag- 
ment containing the !3-globin gene and all the known 
regulatory sequences immediately in and around the 
gene, and a 12 kb region downstream of the p-globin gene 
(+12 kb Kpnl to +24 kb BamHI) containing the down- 
stream hypersensitive site (Figure 2). These regions con- 
tained or were provided with unique linkers to create a se- 
ries of unique restriction sites (Sall, Xhol, Clal, Kpnl, and 
Pvul) and were cloned into the cosmid pTCF (Grosveld et 
al., 1982). The entire 38 kb insert was excised from the 
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Figure 3. Construction of the Human 6-Globin Minilocus 
The human 6-globin locus is illustrated at the top; sizes are shown in kb. The second line shows the 6-globin minilocus, containing a number of 
unique restriction sites; the connecting lines indicate the original positions of the fragments in the f3-globin locus. The sizes of the EcoRI, BarnHI, 
and Hindlll restriction fragments in the minilocus are shown below in kb. The hybridization probes for the 5’ flanking region (EcoRI-Bglll 0.46 kb), 
the 6-globin gene (BarnHI-EcoRI 0.7 kb, IVS II). and the 3’ flanking region (EcoRI 1.15 kb) are shown at the bottom. 
cosmid as a Sal1 fragment, purified from low-melting-point 
agarose, and injected into fertilized mouse eggs (Kollias 
et al., 1986). 
Transgenic Mice Containing the P-Globin Minilocus 
Initial injection of mouse eggs was carried out with a DNA 
concentration of 2 kg/ml; the eggs were transplanted back 
into mice, but no offspring were obtained (for unknown 
reasons). Several series of injections were then carried 
out with a DNA concentration of 0.5-l pg/ml, and fetuses 
were collected after either 12.5 or 13.5 days of gestation. 
DNA was prepared from individual placentas, Southern 
blotted, and hybridized with a human 8-globin probe to de- 
termine the number of transgenic mice, as described pre- 
viously (Kollias et al., 1986). The transgenic DNAs were 
subsequently digested with EcoRI, Southern blotted, and 
hybridized with a human f3-globin probe and a mouse Thy- 
1 probe (single-copy) to determine the number of genes 
integrated in each mouse (Figure 4A and Table 1). These 
values varied from a single insert (mice 33 and 38) to over 
one hundred copies per cell (mouse 21). 
We then determined whether the inserted DNA was in- 
tegrated intact or whether deletions and/or rearrange- 
ments had taken place after injection. Total DNA was 
digested with BarnHI or Hindlll, Southern blotted, and 
probed for the presence of the complete construct. In par- 
ticular, a 0.46 kb Bglll probe (Figure 3) was used to detect 
the 15 kb BamHl fragment at the 5’ end of the construct 
(Figure 48) and a 1.15 kb EcoRl probe (Figure 3) was 
used to detect the 14.6 kb BamHl or 18 kb Hindlll fragment 
Table 1. Levels of Human p-Globin RNA and DNA in Transgenic Mice 
Mouse No. p/a RNAa 6iThy-1 DNA= RNA/DNA 
12 1 .o 
17 42.0b 
21 N.D.C 
24 0.3 
27 10.2 
33 0.5 
36 10.1 
38 <o.i 
40 7.9 
Hull cell line 0.3 
1.0 
47.2b 
>lOO 
11.8 
0.5 
6.7 
0.4 
7.2 
0.5 
1 .o 
0.9 
N.D. 
N.D. 
0.85 
1.0 
1.15 
<0.25 
1.1 
0.6 
All values were normalized to mouse 12 as 1 .O (e.g., see Figures 4A 
and 6C) after densitometric scanning of autoradiographs exposed for 
different times from several experiments. 
a The ratios were obtained by dividing the human 6-globin RNA and 
DNA signals by those obtained for mouse a-globin RNA and Thy-l 
DNA, respectively. Mouse 34 RNA was measured in only one experi- 
ment and not included. 
b The DNA of mouse 17 was partially degraded (see Figure 4). We 
therefore used a low molecular weight cross-hybridizing band on the 
Thy-l blot to quantitate the copy number (rather than the degraded 
6 kb EcoRl Thy-l band). 
c The ratio of human 6-globin to mouse a-globin RNA was not deter- 
mined (N.D.) accurately in this mouse because of the very high human- 
to-mouse RNA signals (see text). 
d Mouse 24 is mosaic for the human 6-globin gene (Figure 6) and 
could therefore not be quantitated. 
at the 3’end of the construct (Figure 4C). All but two of the 
trangenic mice appeared to have intact 8-globin miniloci, 
which are integrated in tandem arrays (not shown) as 
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Figure 4. Structural Analysis of the Human 8-Globin Transgene 
(A) Approximately 5 ug of placental or yolk sac DNA was digested with EcoRI, Southern blotted after gel electrophoresis. and hybridized to either 
the human 8-globin BamHI-EcoRI IVS II probe (see Figure 3) or a mouse Thy-i probe. The gels were quantitated by densitometric scanning of differ- 
ent exposures. The DNA of mouse 17 was partially degraded, and therefore a lower molecular weight Thy-l cross-hybridizing band was used to 
quantitate this sample. The inset at the bottom of the figure is a long exposure (10x) of the globin hybridization to show the low copy signals. 
(8) Placental or yolk sac DNA was digested with BamHI, Southern blotted, and hybridized to a 5’ flanking probe (EcoRI-BamHI 0.46 kb; Figure 3). 
(C) Placental or yolk sac DNA was digested with BamHl or Hindlll, Southern blotted, and hybridized to a 3’flanking probe (EcoRI 1.15 kb; Figure 3). 
In all panels samples contained mixed-in marker DNA (X DNA digested with BstEll or Hindlll). The transgenic mice are numbered above the lanes; 
empty lanes contain DNA samples from nontransgenic mice. Sizes are in kb. Some of the DNA samples are partially digested, although the mixed-in 
1 DNA control was completely digested (not shown). This results in bands that are larger than the 14.6 kb BamHl fragment (14.6 kb + 3.2 kb + 
3.3 kb) or the 18 kb Hindlll fragment (18 kb + 2.4 kb + 3.4 kb) because of cleavage at the next BamHl or Hindlll site in the tandem arrays. 
judged by the presence of the correctly sized fragments. Figure 58 shows an analysis of the 3’ end of the human 
It should be noted, however, that the BamHl and Hindlll f3-globin RNA in the presence of a mouse a-globin probe 
sites at the 3’ end of the locus (Figures 4 and 6) are very as an internal control. These results show that the human 
resistant to cleavage, even though the mixed-in control h f3-globin transcript is correctly initiated and polyadenyl- 
DNA has been fully digested (see Experimental Proce- ated and that the levels of RNA are proportional to the 
dures). This results in partial-cleavage bands that are number of copies of the minilocus in each mouse (except 
larger than the fully digested BamHl (14.6 kb) and Hindlll mice 24 and 38; see below). Nonerythroid tissue does not 
(16 kb) fragments. Transgenic mouse 38 has not retained show any human 6-globin mRNA except when it is con- 
a full copy of the @globin minilocus. The single copy pres- taminated with blood during isolation. In such cases, low 
ent in this mouse has lost the BamHl and Hindlll sites up- levels of both human and mouse 6-globin RNA are found 
stream of the f3-globin gene, although the EcoRl site is still with the same ratio as in erythroid tissue. The level of ex- 
present. This indicates that all the Vflanking DNA, includ- pression is clearly very high when the ratio of the human 
ing the whole hypersensit ive site region, has been deleted f3-globin to mouse 6-globin RNA levels (Table 1) is com- 
in this mouse. Mouse 12 has suffered a small (<1 kb) dele- pared to that of the Hull cell control (Zavodny et al., 1963); 
tion of sequences at the 3’ end of the insert, but this does the latter cell line is an MEL cell line containing the human 
not include the 3’ hypersensit ive site. 5-globin locus on a human X-11 hybrid chromosome. 
The Human @Globin Minilocus Is Fully Active 
To measure the activity of the human f3-globin gene, RNA 
was prepared from all the transgenic and nontransgenic 
fetuses (liver, blood, and brain) and analyzed by Sl 
nuclease protection analysis. Figure 5A shows the analy- 
sis of liver RNA using a 5’ human 6-globin probe, while 
To carefully quantitate the levels of expression in these 
mice, we analyzed the RNA levels in mice 33 and 12, 
which have one and two intact copies of the 6-globin lo- 
cus, and in the two exceptions, mice 24 and 36, using 
mouse and human b-globin probes of equal specific activ- 
ity. Figure 5C shows that the signal of the human 6-globin 
gene is approximately half that of the mouse @globin 
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Figure 5. Expression Analysis of the Human 6-Globin Transgene 
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(A) Five microgram aliquots of RNA from 12.5 or 13.5 day livers from different mice (numbers above lanes) were analyzed by Sl nuclease protection 
as described previously (Kollias et al., 1966). The protected fragment of the 5’ human a-globin probe (525 bp Accl fragment from an IVS l-lacking 
5-globin gene) is 160 nucleotides long. (5’ Eglo). The input probe is shown as ip. The marker lane (m) contains pBR322 DNA digested with Hinfl; 
sizes are indicated in nucleotides. The positive control is RNA from the hybrid MEL cell line Hull (lane hu). 
(B) Five microgram aliquots of RNA were analyzed as in (A), but using two probes: a 3’ probe of the human 6-globin gene (760 bp EcoRI-Mspl 
fragment), resulting in a 210 nucleotide protected fragment (H beta); and a mouse a-globin probe (260 bp BamHl second exon probe), resulting 
in a 170 nucleotide protected fragment (M alpha). Other designations are as in (A). 
(C) Five microgram aliquots of RNA were analyzed as in (B), but in addition a mouse pmaj-globin probe (a 730 bp second exon probe) was added, 
resulting in a 100 nucleotide protected fragment (M beta). The probes were of equal specific activity. The activity of the probes was assessed by 
quantitative agarose gel electrophoresis and autoradiography of the individual probes before and after mixing for the Sl nuclease analysis (not 
shown). Each probe was individually tested with Hull RNA (hu) or nontransgenic mouse fetal liver RNa (ml). 
(D) Samples of fetal liver (approximately 20 ug) or human red cells were lysed in 40 nl of Hz0 and the globin proteins were separated, as described 
by Alter et al. (1960). The gel was stained to visualize the globin protein chains. Mouse 9 is an age-matched, nontransgenic littermate of mouse 
12. The positions of mouse a- and f3-globin and human P-globin are indicated. 
diploid in mouse 33, but the signals are equal in mouse 
12. This is confirmed at the protein level, when the red 
cells of mouse 12 and an age-matched control are lysed 
and the proteins run on a Triton-acid-urea gel (Alter et al., 
1980). It is clear that transgenic mouse 12 expresses 
equal levels of mouse and human 8-globin proteins (Fig- 
ure 5D). From all these data we conclude that each human 
8-globin gene in these mice is fully active, i.e., is ex- 
pressed at a level equivalent to that of the mouse @globin 
genes, while the expression in mice 24 and 38 is sup- 
pressed. A peculiar situation is found in mice 21 and 17. 
The mouse 8-globin RNA levels are very low in these 
mice, presumably as a result of the very high copy number 
of the human 8-globin gene and, as a consequence, the 
very high mRNA (and protein) levels. The high copy num- 
ber possibly results in a competition for transcription fac- 
tors (mouse @globin RNA is decreased more than mouse 
a-globin RNA; Figure 58) while the high levels of 8-globin 
protein definitely result in an anemia (a-thalassemia). 
Mice 21 and 17 had small, colorless livers, consistent with 
the destruction of mature red cells and concomitant loss 
of mRNA. 
Two mice (38 and 24) are exceptions because they ex- 
press relatively lower amounts of human 8-globin (Figures 
5A-5C; Table 1). The situation in mouse 38 is explained 
by the fact that this is the only transgenic mouse in which 
the 5’ end of the locus is deleted (Figure 4). As a conse- 
quence, the human 8-globin gene is still expressed, but 
in a position-dependent manner and at low levels, just as 
when small 8-globin fragments are introduced in mice 
(Kollias et al., 1986; Magram et al., 1985; Townes et al., 
1985). Mouse 24 has no apparent defect in the locus, and 
we investigated the possibility that this mouse is a true ex- 
ception or whether it is a mosaic mouse or has the 8-glo- 
bin locus integrated on an inactive X-chromosome. We 
therefore isolated DNA from the yolk sac, brain, and fetal 
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liver (the “erythroid” tissue) and hybridized the EcoRI- 
digested DNAs on Southern blots with a human b-globin 
probe and a murine Thy-l probe, to detect the f3-globin 
yolk sac DNA; i.e., fewer than 25% of the liver cells contain 
the f3-globin gene. This is therefore a mosaic mouse in 
which the b-globin minilocus is underrepresented in the 
erythroid tissue (fetal liver), which explains the lower lev- 
els of human f3-globin mRNA found in these cells. We con- 
clude that provided the locus has not been affected, there 
is a complete correlation between expression levels and 
DNA copy numbers and that each gene is fully expressed 
in every transgenic mouse. 
Figure 6. Mouse 24 Is Chimeric for the Human 6-Globin Gene 
Five micrograms of yolk sac (ys) DNA and 10 ug of fetal liver (Iv) and 
brain (br) DNA were digested with EcoRI, Southern blotted, and hybrid- 
ized as described in Figure 4A. 
Mapping DNAase l-Hypersensitive Sites 
in the Transgenic b-Globin Locus 
The DNAase l-hypersensitive sites flanking the 5-globin 
locus are found in all erythroid tissues studied, regardless 
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Figure 7. DNAase I-Hypersensitive Sites Are Reformed on the Transgenic j3-Globin Minilocus 
(A-F) Nuclei of mouse 21 tissues were incubated at 37% with DNAase I at 5 uglml for 0, 1, 2, 4, or 6 min (liver), or 0, 1, 2, 5, or 10 min (brain). 
Control aliquots of nuclei were incubated for 6 or 10 min in the absence of DNAase I (lanes 0 enz.). Purified DNA was recut with BamHI, fractionated 
on a 0.6% agarose gel, transferred to nitrocellulose, and probed with DNA fragments spanning the transgenic human 6-globin minilocus. The 14.0 
kb BamHl fragment detected by probe D in (F) is a junction fragment of the tandem array of the 6-globin minilocus. The 17.8 kb band is the result 
of incomplete BamHl digestion. (G) is a schematic representation of a repeat unit of the minilocus tandem array in mouse 21; DNAase I-hypersensi- 
tive sites are marked. Site 5 is not reformed in fetal liver nuclei (F). DNAase I subbands corresponding to hypersensitive sites 1 and 2 are not seen 
in DNAase I fade-out experiments, but the BamHl fragments in which they reside are sensitive to DNAase I digestion in liver (A and C) but not brain 
(B and D). 
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of which p-like globin is expressed. To determine if the 
DNAase l-hypersensitive sites are reformed in the p-gio- 
bin minilocus of transgenic mice expressing high levels of 
human P-globin mRNA, a DNAase I “fade-out” was per- 
formed on small samples of liver and brain nuclei of 
mouse 21 (which has the highest copy number of the p 
gene minilocus) (Figure 7). Limited DNAase I digestion 
was carried out in the presence of carrier fetal liver or 
brain nuclei; purified nuclear DNA was recut with BamHI, 
fractionated, and Southern blotted, and fragments span- 
ning the whole construct were used as hybridization 
probes. The 1.15 kb EcoRl probe used to detect the 3’ 
hypersensit ive site in HEL and PUTKO cells detects a 17.8 
kb BamHl fragment, which is due to partial digestion of 
the BamHl site at the S’end of the injected fragment. The 
17.8 kb BamHl fragment is completely insensitive to 
limited DNAase I digestion in liver nuclei of mouse 21 (Fig- 
ure 7F). The same filter reprobed with a 600 bp Accl5’hu- 
man P-globin probe shows that the 2.0 kb BamHl fragment 
encompassing the Vend (to -1460 bp) of the highly tran- 
scribed human P-globin gene is slightly sensitive to 
DNAase I digestion, revealing a DNAase I subband of ap- 
proximately 1 kb (Figure 7E), consistent with a DNAase 
l-hypersensitive site within the B-globin gene promoter 
(Groudine et al., 1983). Reprobing the same filter with the 
0.46 kb EcoRI-Bglll probe (Figure lc) shows that the 15 
kb BamHl fragment encompassing hypersensit ive sites 2, 
3a, 3b, and 4 is exceedingly sensitive to DNAase I diges- 
tion in fetal liver nuclei; subbands corresponding to cut- 
ting at sites 3 and 4 are clearly visible. The same 15 kb 
BamHl fragment of the p transgene minilocus is insensi- 
tive to DNAase I digestion in brain nuclei of the same ani- 
mal (Figure 7D). The 3.3 kb BamHl fragment (containing 
hypersensit ive site 1) of the transgenic minilocus is also 
very sensitive to DNAase I digestion in liver, but not brain 
nuclei of mouse 21 (Figures 7A and 78). In summary, the 
5’ flanking region is extremely sensitive to DNAase I 
digestion and has retained the superhypersensit ive sites 
in a tissue-specific fashion. Surprisingly, the 3’flanking re- 
gion is insensitive to DNAase I digestion, and the su- 
perhypersensit ive site is not retained. The normal hyper- 
sensitivity in the promoter is present (Groudine et al., 
1983). 
Discussion 
Position-Effect-Independent Expression 
The introduction of the human b-globin gene flanked by 
the upstream and downstream regions in transgenic mice 
has resulted in an expression pattern that is position- 
independent and directly related to copy number, with lev- 
els of human (3-globin mRNA as high as mouse B-globin 
mRNA. This is different from results observed previously 
with transgenic mice created using the P-globin gene 
alone (Magram et al., 1985; Chada et al., 1985; Townes et 
al., 1985; Kollias et al., 1986, 1987) or other genes such 
as the immunoglobulin genes (Grosschedl et al., 1984), 
albumin genes (Pinkert et al., 1987), the Thy-l gene (Kol- 
lias et al., 1987), the a-fetoprotein gene (Hammer et al., 
1987), and many others. As a result of position effects in 
all transgenic mice experiments to date, the level of trans- 
genie expression has been suboptimal and has varied be- 
tween different mice; i.e., there has been no strict correla- 
tion between the copy number of the transgene and the 
level of expression. Therefore it has been very difficult to 
quantitate any experiments accurately, and as a result, it 
has been impossible, for example, to examine the cooper- 
ation between regulatory elements in any gene. The 
results described in this paper indicate that this problem 
can be overcome, at least for the human P-globin genes. 
It is clear that the expression levels found in mice contain- 
ing the intact minilocus are directly proportional to the 
number of genes incorporated (Table 1). In addition, the 
expression level per human P-globin gene in all of those 
mice is very similar to that observed for the endogenous 
mouse P-globin gene (Figure 5). We therefore conclude 
that the P-globin locus flanking sequences confer posi- 
t ion-independent expression on the P-globin gene, which 
itself is expressed erythroid-specifically. In addition, we 
conclude that all of the regulatory sequences involved in 
P-globin gene expression are included in this construct. 
The Requirement for and Function of 
the Flanking Regions 
It is not clear from these data what minimal sequences in 
the flanking regions are required for the complete and in- 
dependent expression of the gene. Certainly, the 5’flank- 
ing region is required. Deletion of the upstream region in 
vivo results in a Do thalassemia (Kioussis et al., 1983; 
Curtin and Kan, 1987), and deletion of this region in 
mouse 38 (Figure 4) results in reduced expression (Figure 
5). In heterozygous Dutch rS-thalassemia patients there 
are no secondary mutations in the affected gene; all the 
regulatory regions normally near or within the gene are 
present, and all the factors required to transcribe the gene 
are present in the nucleus, since the second (normal) al- 
lele is expressed with normal efficiency. The same argu- 
ment is true for mouse 38, which expresses normal levels 
of mouse P-globin. This shows that this region exerts a 
dominant control on the expression of the P-globin locus. 
It is tempting to speculate from the DNAase I sensitivity 
data (Figure 7) that only the 5’ region, but not the 3’ region, 
is required, and that the actual active regions are the se- 
quences at the hypersensit ive sites. It should be pointed 
out, however, that the presence or absence of hypersensi- 
tive sites may not necessarily correlate with the control re- 
gion of position-independent expression, and that the 3’ 
flanking region might also be important, although it is 
clear that the 3’ region alone is not sufficient (mouse 38, 
Figure 4). 
The control region(s) in the flanking DNA is completely 
dominant (see above), and the hypersensit ive sites are 
erythroid-specific and present at all erythroid develop- 
mental stages (Figures 1,2, and 7; Tuan et al., 1985). They 
are even dominant after fusion of a globin-expressing cell 
line (K562) to a nonerythroid cell line myeloma (Klein et 
al., 1980), resulting in a globin-expressing hybrid cell 
(PUTKO) (see Figures 1 and 2). It is likely that the regions 
control the accessibility of the (3-globin locus to trans- 
acting factors, perhaps like the border regions flanking the 
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DNAase l-sensitive domain originally described for the 
ovalbumin gene (Lawson et al., 1982). These borders may 
contain nuclear-matrix-binding sites, which have been 
poorly defined in mammalian cells but have been mapped 
in detail in Drosophila (Gasser and Laemmli, 1986). Alter- 
natively, the globin locus flanking regions might contain 
one or several enhancer-l ike sequences, which can exert 
their effect over very large distances (>50 kb) and would 
be required to set up efficient transcription complexes. An 
attractive possibility is that such enhancers and matrix- 
binding sites are actually the same or neighboring se- 
quences (Cockerhill and Garrard, 1986). It is likely that 
similar control regions will be present in other tightly con- 
trolled, tissue-specific gene systems. To date, all experi- 
ments with other genes in transgenic animals have been 
carried out with small fragments and have been subject 
to position effects. However,  genes expressed at low lev- 
els and those expressed ubiquitously may be controlled 
differently. 
It is not clear whether the sequences we describe here 
are specific for P-globin genes, or whether they might also 
be present in the a-globin gene locus, providing coor- 
dinate regulation. A recently described a-thalassemia 
shows a deletion in the 5’flanking region of the locus simi- 
lar to that described for the yfl-thalassemia (Nicholls et al., 
1987). It is also not yet clear whether these sequences will 
exert a similar dominant effect on other genes. To answer 
this question, we are currently testing the expression of 
heterologous genes cloned into the P-globin minilocus 
construct. 
The Mechanism of D-Globin Gene Switching 
We have now identified at least five different control 
regions in the S-globin gene: the dominant control region 
described in this paper, positively negatively acting se- 
quences in the promoter (Antoniou and Grosveld, sub- 
mitted; Grosveld et al., 1987), and two enhancer se- 
quences, one in the gene and one in the immediate 3’ 
flanking region (Kollias et al., 1987; Townes et al., 1987; 
Costantini et al., personal communication). On  that basis, 
we propose the following model for the control of globin 
gene expression during development: The dominant con- 
trol region determines the activity of the locus. In inactive, 
nonerythroid tissues there are no hypersensit ive sites, 
and the DNA is not accessible to trans-acting factors. In 
erythroid cells the dominant control region becomes 
extremely hypersensit ive (possibly not requiring repli- 
cation) and renders the chromatin of the globin locus 
accessible to trans-acting factors. The proteins that medi- 
ate this action might be matrix-bound, such as topoiso- 
merases to change the winding of the locus and/or en- 
hancer-binding factors (Angel et al., 1987; Lee et al., 1987). 
This control defines the globin domain and provides posi- 
t ion-independent expression. Action of the dominant con- 
trol region then mediates the binding of Vans-acting fac- 
tors to regulatory promoter and enhancer sequences 
immediately surrounding the globin genes. This process 
determines the stage-specific expression-i.e., E-globin 
gene expression in the embryonic yolk sac, y-globin gene 
expression in the fetal liver, and 6-globin gene expression 
in the adult. In the case of the P-globin gene, this process 
would involve a negative factor and regulatory sequence 
to suppress the gene at the embryonic and fetal stages, 
and positive factors acting on the enhancers and the 
promoters to set up a very active transcription complex. 
Gene Therapy 
Perhaps the most interesting application for the dominant 
control region(s) is that it might allow completely regulated 
expression of the P-globin gene (and possibly other 
genes) in retroviral vector or transfection systems. Gene 
expression in such systems is at present position-depen- 
dent and inefficient. In particular, retroviral vector sys- 
tems, which are currently the only efficient means of trans- 
ferring genes into hematopoietic (or other) stem cells, are 
very sensitive to the integration site of the retroviral vector 
(Cone et al., 1987). Inclusion of the globin dominant con- 
trol regions may solve this problem and allow the efficient 
transfer of a fully active, single-copy human globin gene 
to hematopoietic stem cells. This would form the basis for 
gene therapy by gene addition in the case of thalassemias. 
Experimental Procedures 
Transgenic Mice 
The 38 kb Sall fragment was purified from cosmid vector sequences 
by gel electrophoresis and prepared for injection as previously de- 
scribed (Kollias et al., 1986; Brinster et al.. 1985). Transgenic fetuses 
were identified by Southern blot analysis (Southern, 1975) of placental 
DNA. 
RNA Analysis 
RNA extraction of different tissues and Si nuclease protection analysis 
were carried out as described previously (Kollias et al., 1986). 
DNAsse Sensitivity 
DNAase I sensitivity assays were carried out on isolated nuclei as de- 
scribed by Enver et al. (1985), except that 1 mM EGTA was included 
In all buffers until DNAase I digestion in buffer A plus 1 mM CaCI, 
was performed. In the case of transgenic liver and brain, four livers and 
brains from age-matched normal fetuses were added as carriers to pro- 
vide sufficient material to carry out the analysis. 
Construction of the B-Globin Minilocus 
-A 12 kb Bglll fragment (IO-22 kb 5’of the b-globin gene) was cloned 
into the BamHl site of cosmid pTCF (Grosveld et al., 1982) without a 
Clal site. forming cos HGB12. 
-cos HGBl2 was cleaved with Asp718 (13.5 kb 5’of the c-globin gene), 
and a unique Xhol linker was inserted, forming cos HGBlZX. 
-cos HG14.2 (Taramelli et al., 1986), containing the entire &-globin up- 
stream region, was cleaved with Kpnl, and an Xhol linker was inserted 
and packaged, forming cos HG14.2X. 
-A Clal linker was inserted in the Xbal site of pUC18, to form pUC18C. 
-The 4.7 kb Bglll fragment containing the b-globin gene was inserted 
in the BamHl site of pUC18C. yielding plJC18C-BG. 
-A 12 kb Hpal-BamHI fragment (12-24 kb 3’of the @globin gene) was 
cloned into the Hpal-BamHI site of cosmid pTCF lacking a Cla site, 
forming cos HGHB12. 
-The final cosmid construct was formed by the ligation and packaging 
of four fragments: a 16.5 kb Pvul-Xhol fragment from cos HGBlPX con- 
taining the cosmid and part of the upstream sequences, an 11 kb 
Xhol-Clal fragment from cos HG14.2X containing the remainder of the 
upstream sequences, a 4.7 kb Clal-Kpnl fragment from pUC18C-BG 
containing the 8-globin gene, and a 19 kb Kpnl-Hpal fragment from 
cos HGHBl2 containing the 3’flanking region and the second cosmid 
for packaging purposes. The final construct was the cos HG minilocus 
(Figure 3). 
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